BioHarvest SciencesBHST -1.42%64 Current Ratio is 2.96 as of Mar. 2026, which is 199% above its 10-year median of 0.99. GuruFocus rates BHST with a GF Score™ of 64/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,988 Consumer Packaged Goods companies, BioHarvest Sciences ranks better than 74.8% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. BioHarvest Sciences's current ratio for the quarter that ended in Mar. 2026 was 2.96.
BioHarvest Sciences has a current ratio of 2.96. It generally indicates good short-term financial strength.
The historical rank and industry rank for BioHarvest Sciences's Current Ratio or its related term are showing as below:
BHST'
s Current Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.99 Max: 32.15
Current: 2.96
During the past 12 years, BioHarvest Sciences's highest Current Ratio was 32.15. The lowest was 0.02. And the median was 0.99.
BHST's Current Ratio is ranked better than 74.8% of 1988
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs BHST: 2.96
BioHarvest Sciences (NAS:BHST) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
BioHarvest Sciences Current Ratio Related Terms
BioHarvest Sciences Current Ratio Historical Data
* Premium members only.
The historical data trend for BioHarvest Sciences's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BHST vs GWLL, CLNN, FTLF: Current Ratio Comparison
For the Packaged Foods subindustry, BioHarvest Sciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Current Ratio distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioHarvest Sciences (BHST) has a Current Ratio of 2.96 as of Mar. 2026. This is 199% above median its historical median of 0.99. Over the past decade, BioHarvest Sciences' Current Ratio has ranged from 0.02 to 32.15. According to the industry distribution chart, BioHarvest Sciences ranks #501 out of 1988 companies in the Consumer Packaged Goods industry, placing it in the top 25.2%.
Is BioHarvest Sciences' Current Ratio too high?
BioHarvest Sciences' current Current Ratio of 2.96 is 199% above median its 10-year median of 0.99. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 32.15. The Consumer Packaged Goods industry median Current Ratio is 1.73. BioHarvest Sciences' value of 2.96 is 71.1% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #501 out of 1988 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, BioHarvest Sciences has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Current Ratio compare to GWLL and CLNN?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #501 out of 1988 companies for Current Ratio. This puts BioHarvest Sciences in the upper half of its industry. The industry median Current Ratio is 1.73. BioHarvest Sciences' value of 2.96 is 71.1% above this benchmark. Historically, BioHarvest Sciences' own Current Ratio has ranged from 0.02 to 32.15 over the past decade. While the company's 10-year median is 0.99 vs. the industry median of 1.73, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,988 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current Current Ratio of 2.96 is 71.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current Current Ratio is 2.96, which is 199% above median its own 10-year median of 0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.77 — trading 67.7% below its estimated fair value. The current Current Ratio is 2.96, which is 199% above median its 10-year median of 0.99 and 71.1% above the Consumer Packaged Goods industry median of 1.73. BioHarvest Sciences' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Current Ratio is 2.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $2.77 is trading 67.7% below its estimated GF Value™ of $8.57.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
Current Ratio: 2.96 (199% above median its 10-year median of 0.99)
GF Value™: $8.57 vs. price of $2.77 (67.7% below fair value)
Industry Position: 71.1% above the Consumer Packaged Goods median (#501 of 1988)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
64GF Score
Get the complete analysis for BHST
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
